Bans step therapy requirements for neurological conditions

File SF5187 ("Bans step therapy requirements for neurological conditions") is before the Minnesota Legislature and has not been decided. Latest step (April 22, 2026): Author added.

Minnesota file SF5187, before the Minnesota Legislature. Still to be decided as of 2026-04-22.

What it does

Get prescribed neurological drugs without forced cheaper alternatives first Patients whose doctors prescribe specific treatments for neurological conditions (Parkinson's, epilepsy, MS, etc.) can fill those prescriptions immediately instead of first proving failure on lower-cost drugs required by insurers.

The bigger picture

Insurance costs may rise as step therapy restrictions limit cost controls Insurers lose a cost-containment tool that previously required cheaper drugs first; this may shift claim-approval patterns and potentially increase premium costs across neurological coverage pools.

What to watch

Applies only to Minnesota; narrower than other state neurology bills The bill's scope covers only Minnesota insurers and state-regulated plans, leaving federal employees, out-of-state insurers, and self-insured employer plans outside its reach.

Official summary

Use of step therapy protocols prohibition for the treatment of neurological conditions

Read the official record for SF5187

See everything up for a vote · This week in Minnesota · See what we have filed with the clerk